Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Long-Term Debt Repayments: 2013-2019

Historic Long-Term Debt Repayments for Altimmune (ALT) over the last 2 years, with Dec 2019 value amounting to $105,062.

  • Altimmune's Long-Term Debt Repayments was N/A to $105,062 in Q4 2019 from the same period last year, while for Dec 2019 it was $216,955, marking a year-over-year change of. This contributed to the annual value of $632,000 for FY2020, which is 116.44% up from last year.
  • As of Q4 2019, Altimmune's Long-Term Debt Repayments stood at $105,062, which was up 241.17% from $30,795 recorded in Q3 2019.
  • Over the past 5 years, Altimmune's Long-Term Debt Repayments peaked at $105,062 during Q4 2019, and registered a low of -$250,009 during Q3 2015.
  • In the last 1 years, Altimmune's Long-Term Debt Repayments had a median value of $67,928 in 2019 and averaged $67,928.
  • Its Long-Term Debt Repayments has fluctuated over the past 5 years, first declined by 0.00% in 2015, then spiked by 100.04% in 2016.
  • Quarterly analysis of 3 years shows Altimmune's Long-Term Debt Repayments stood at -$250,009 in 2015, then spiked by 100.04% to $80,999 in 2016, then reached $105,062 in 2019.
  • Its Long-Term Debt Repayments was $105,062 in Q4 2019, compared to $30,795 in Q3 2019 and $80,999 in Q4 2016.